101 related articles for article (PubMed ID: 29353292)
1. Harm reduction program use, psychopathology and medical severity in patients with methadone maintenance treatment.
Martínez-Luna NG; Rodríguez-Cintas L; Esojo A; Palma-Álvarez RF; Robles-Martínez M; Grau-López L; Perea M; Roncero C
Adicciones; 2018 Jan; 30(3):197-207. PubMed ID: 29353292
[TBL] [Abstract][Full Text] [Related]
2. Methadone Medical Maintenance: An Early 21st-Century Perspective.
Novick DM; Salsitz EA; Joseph H; Kreek MJ
J Addict Dis; 2015; 34(2-3):226-37. PubMed ID: 26110221
[TBL] [Abstract][Full Text] [Related]
3. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
[TBL] [Abstract][Full Text] [Related]
4. When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.
Reimer J; Boniakowski E; Bachner C; Weber B; Tietje W; Verthein U; Walcher S
Subst Abuse Treat Prev Policy; 2014 Feb; 9():13. PubMed ID: 24581310
[TBL] [Abstract][Full Text] [Related]
5. Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment.
Peles E; Schreiber S; Domany Y; Adelson M
World J Biol Psychiatry; 2014 Dec; 15(8):629-35. PubMed ID: 25140586
[TBL] [Abstract][Full Text] [Related]
6. Heroin-assisted treatment for opioid dependence: randomised controlled trial.
Haasen C; Verthein U; Degkwitz P; Berger J; Krausz M; Naber D
Br J Psychiatry; 2007 Jul; 191():55-62. PubMed ID: 17602126
[TBL] [Abstract][Full Text] [Related]
7. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
[TBL] [Abstract][Full Text] [Related]
8. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
[TBL] [Abstract][Full Text] [Related]
9. Methadone for the treatment of Prescription Opioids Dependence. A retrospective chart review.
Barrio P; Ezzeldin M; Bruguera P; Pérez A; Mansilla S; Fàbrega M; Lligoña A; Mondón S; Balcells M
Adicciones; 2016 Jun; 29(1):55-60. PubMed ID: 27391853
[TBL] [Abstract][Full Text] [Related]
10. [The impact of substitution treatment by methadone among opiate-dependent subjects evaluated by Addiction Severity Index and by urine tests].
Trémeau F; Darreye A; Khidichian F; Weibel H; Kempf M; Greth P; Schneider JL; Wantz C; Weber B; Stépien S; Macher JP
Encephale; 2002; 28(5 Pt 1):448-53. PubMed ID: 12386547
[TBL] [Abstract][Full Text] [Related]
11. Effect of psychiatric severity on the outcome of methadone maintenance treatment.
Pani PP; Maremmani I; Pacini M; Lamanna F; Maremmani AG; Dell'osso L
Eur Addict Res; 2011; 17(2):80-9. PubMed ID: 21178355
[TBL] [Abstract][Full Text] [Related]
12. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
Fingerhood MI; King VL; Brooner RK; Rastegar DA
Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
[TBL] [Abstract][Full Text] [Related]
13. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
14. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
Verthein U; Haasen C; Reimer J
Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
[TBL] [Abstract][Full Text] [Related]
15. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
[TBL] [Abstract][Full Text] [Related]
16. [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
Trémeau F; Darreye A; Leroy B; Renckly V; Ertlé S; Weibel H; Khidichian F; Macher JP
Encephale; 2003; 29(4 Pt 1):285-92. PubMed ID: 14615698
[TBL] [Abstract][Full Text] [Related]
17. [Use of methadone therapy at the Institute for Alcoholism and Drug Addiction in the Canton of Sarajevo].
Hasecić H; Mehić-Basara N; Pokrajac M; Marjanović-Cengić S; Selman S; Ploskić S; Ramić L; Balić A; Grabovica M; Havić E; Sukurović N
Med Arh; 2003; 57(5-6 Suppl 1):29-32. PubMed ID: 15022566
[TBL] [Abstract][Full Text] [Related]
18. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
19. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
[TBL] [Abstract][Full Text] [Related]
20. ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Farré M; Estivill X; Torrens M
Eur Neuropsychopharmacol; 2014 Mar; 24(3):420-4. PubMed ID: 24230997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
